ESH Video

#ESHIMMUNE2024 HAS BEEN GRANTED 19,5 CME-CPD CREDIT POINTS

August 27, 2024

 

3rd Translational Research Conference

IMMUNE & CELLULAR THERAPIES:

Focus on Advanced Gene-Engineered Immune Cells

 

September 13-15, 2024

Malahide (Dublin), Ireland

#ESHIMMUNE2024

Chairs: Chiara Bonini, Michael Hudecek, Stanley Riddell

 


 

The conference's programme has been approved for 
19,5 CME-CPD credit points
by the European Board for Accreditation in Haematology (EBAH)!

Join us in Ireland in September:

 

 


 

CONFERENCE'S MAIN SCIENTIFIC TOPICS
• Clinical development of CAR-T cell therapy
• Emerging targets for cell therapy
• Receptor engineering for tumor therapy
• Gene editing to enhance efficacy
• Novel cell types and sources – beyond autologous
• Engineering immune cells in vivo
• Correlative analyses of response and resistance
• Overcoming barriers to improve response
• The future of engineered cell therapy

 

 


 

About the Conference:

The ESH 3rd TRANSLATIONAL RESEARCH CONFERENCE: IMMUNE & CELLULAR THERAPIES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune & cellular therapies with a focus on advanced gene-engineered immune cells.
New data will be presented and spirited debates on how to best to apply these insights to the future of immune & cellular therapies are expected.

 


 

Meet the faculty members:

 

 


 

CLICK HERE TO READ THE SCIENTIFIC PROGRAMME

 

MORE INFORMATION